Many organs play important roles, but not all of them are required for survival. Some are removed because of injury, and ...
The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results